自拟扶正祛邪化瘀汤配合针刺治疗类风湿关节炎的临床观察

摘要/Abstract

摘要： 目的：观察自拟扶正祛邪化瘀汤配合针刺治疗类风湿关节炎（RA）的临床疗效。方法：RA患者80例随机分为观察组和对照组，每组各40例。对照组给予西药常规治疗，观察组在对照组基础上配合自拟扶正祛邪化瘀汤配合针刺治疗，两组均每日1次，连续治疗4周。治疗结束后观察比较两组治疗前后临床症状、实验室指标[包括类风湿因子（rheumatoid factor，RF）、C-反应蛋白（C-reactive protein，CRP）、血沉（erythrocyte sedimentation rate，ESR）、抗环瓜氨酸肽抗体（A-CCP）水平]以及疾病活动度（DAS28评分）。结果：观察组临床总有效率为90.0%，高于对照组的77.5%，差异有统计学意义（P<0.05）；治疗后，两组患者晨僵时间、休息痛、压痛个数、肿胀个数、双手握力和健康状况问卷均较治疗前明显改善（P＜0.05），观察组优于对照组（P＜0.05）；两组患者治疗后RF、CRP、ESR、A-CCP 指标均较治疗前降低（P＜0.05）；观察组较对照组改善明显（P＜0.05）；两组患者治疗后DAS28 评分均较治疗前下降（P＜0.05），观察组DAS28评分均低于对照组（P＜0.05）。结论：自拟扶正祛邪化瘀汤配合针刺治疗RA疗效稳定，可改善RA患者的症状，RF、CRP、ESR、A-CCP 指标等实验室指标以及RA疾病的活动度。

Abstract: Objective：To observe the clinical efficacy of fuzheng quxie huayu decoction combined with acupuncture in the treatment of rheumatoid arthritis (RA). Methods： 80 patients with RA were randomly divided into the observation group and the control group， 40 cases in each group.The control group was given treatment with western medicine.The observation group was given self-made fuzheng quxie huayu decoction combined with acupuncture treatment on the basis of the control group. The two groups were treated 1 time·d-1 and total 4 weeks. After the treatment， the clinical symptoms and laboratory indicators including rheumatoid factor (RF)， C-reactive protein(CRP)， erythrocyte sedimentation rate(ESR)， anti cyclic citrullinated peptide antibody (A-CCP) and disease activity were observed before and after treatment in two groups. Results： The total clinical effective rate of the observation group was 90.0%， higher than that of the control group 77.5% (P<0.05). After the treatment， the morning stiffness time， rest pain， the number of pain， the number of swelling， the grip strength and the health status of the two groups were significantly improved (P<0.05)， and the observation group was better than the control group (P<0.05). After treatment， the indexes of RF， CRP， ESR and A-CCP were lower than those before treatment (P<0.05)， and the improvement of the observation group was higher than that of the control group (P<0.05). The DAS28 scores in the two groups were all lower than those before the treatment (P<0.05)， and the DAS28 scores in the observation group were lower than those in the control group (P<0.05). Conclusion： The effect of self-made fuzheng quxie huayu decoction combined with acupuncture in the treatment of RA is stable， and can improve the symptoms of RA patients， laboratory indexes such as RF， CRP， ESR and A-CCP， as well as the degree of activity of RA disease.

马仲林. 自拟扶正祛邪化瘀汤配合针刺治疗类风湿关节炎的临床观察[J]. .

mazhonglin. Clinical Observation of Rheumatoid Arthritis Treated with Self-made Fuzheng Quxie Huayu Decoction Combined with Acupuncture[J]. .

参考文献

[1]史晓飞, 付建斌. 应重视类风湿关节炎流行病学伴发疾病致残率及就医行为的研究[J]. 中华风湿病学杂志, 2014, 18(7):433-436.
[2]Li Z G. A new look at rheumatology in China-opportunities and challenges.[J]. Nat Rev Rheumatol, 2015, 11(5): 313-3137.
[3]曾小峰, 朱松林, 谭爱春, 等. 我国类风湿关节炎疾病负担和生存质量研究的系统评价[J]. 中国循证医学杂志, 2013, 13(3): 300-307.
[4]王景红, 刘菁华, 汪文琪, 等. 类风湿关节炎常用药物及其不良反应[J]. 中国药房, 2014, 25(48): 4601-4603.
[5]郭丽萍. 中西医结合治疗类风湿关节炎80例疗效观察[J]. 中国药物与临床, 2012, 12(s1):74-75.
[6]Aletaha D, Neogi T, Silman A J, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J].Ann Rheum Dis, 2015, 74(10): 1789–1798.
[7]姚血明, 马武开, 唐芳, 等. 类风湿关节炎患者DAS28积分与疾病活动指标的相关性分析[J]. 中国慢性病预防与控制, 2013, 21(1): 79-81.
[8]中华医学会风湿病学分会. 类风湿关节炎诊断及治疗指南[J]. 中华风湿病学杂志, 2010, 14(4): 265-270.
[9]Mcinnes I B, Schett G. The Pathogenesis of Rheumatoid Arthritis — NEJM[J]. N Engl J Med, 2011, 365(23): 2205-2219.
[10]Niu X, Chen G. Clinical biomarkers and pathogenic-related cytokines in rheumatoid arthritis.[J]. J Immunol Res, 2014, 2014(6182): 698192.
[11]曹玉举. 娄多峰“虚、邪、瘀”理论论治类风湿关节炎[J]. 中华中医药杂志, 2018, 33(2): 569-571.
[12]Torresrosas R, Yehia G, Peña G, et al. Dopamine mediates vagal modulation of the immune system by electroacupuncture.[J]. Nat Med. 2014, 20(3): 291-295.
[13]Zhang R, Lao L, Ren K, et al. Mechanisms of Acupuncture-Electroacupuncture on Persistent Pain[J]. Anesthesiology. 2014 , 120(2): 482-503.
[14]王玲丽, 丰华玲, 杨柯,等. 黄芪生物学及化学成分研究进展[J]. 基因组学与应用生物学, 2017, 36(6): 2581-2584.
[15]凌宗全. 白术化学成分及药理作用研究进展[J]. 内蒙古中医药, 2013, 32(35): 105-106.
[16]陈桂玉, 项东宇. 防风的有效成分及药理学研究进展[J]. 黑龙江医药, 2011, 24(4): 600-601.
[17]袁海建, 李卫, 金建明, 等. 桂枝汤化学成分、药理作用机制与临床应用研究进展[J]. 中国中药杂志, 2017, 42(23): 4556-4564.
[18]王海琨. 白芍总苷在风湿免疫性疾病中的临床应用[J]. 中国实用医药, 2016, 11(10): 280-281.
[19]赵仁霞. 丹参的现代药理研究及临床应用[J]. 中国医药指南, 2011, 09(12): 291-292.
20]赵仁霞. 丹参的现代药理研究及临床应用[J]. 中国医药指南, 2011, 09(12): 291-292.

快速检索引用检索图表检索高级检索